Skip to main content
. 2020 Nov 26;21(23):8993. doi: 10.3390/ijms21238993
UTUC Upper-tract urothelial carcinoma
M-VAC Methotrexate, Vinblastine, Doxorubicin, and Cisplatin
eGFR Estimated glomerular filtration rate
CTLA-4 Cytotoxic T lymphocyte antigen 4
LDHA Lactate dehydrogenase A
GLUT Glucose transporters
GLUL Glutamine synthetase
PD-L1 Programmed death ligand 1
UCB Urothelial carcinoma of the bladder
APC Antigen-presenting cell
PD-1 Programmed death 1
FDA Food and Drug Administration
TME Tumor microenvironment
UC Urothelial carcinoma
AA Aristolochic acid
ICI Immune checkpoint inhibitor
GC Gemcitabine plus cisplatin
NO Nitrous oxide